CIK: 1188989 - Address: , ,
29 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111-449315211
P%wins010010010010010083
S%ret111202-0213298
S%wins58333350421739

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/5/10 13:01
12/21/09
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.ad209.09422910D39402716101111-3-2-115474
12/23/09 09:55
12/21/09
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d209.0952428D37523219121110100-861072
11/4/09 13:16
11/2/09
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.dm4312.96531855D218441031-3-2-33402069
11/4/09 13:16
11/2/09
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.dm-10331.265-3-395D218441031-3-2-33402069
7/30/09 13:59
7/29/09
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d9221.59545225D54719251341-12-3-291048
2/4/09 12:59
2/3/09
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d3912.95931445B-1-3-31-191020
2/4/09 12:59
2/3/09
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.d-8026.689-3-375B-1-3-31-191020
11/21/08 14:24
11/21/08
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPP2221.7871255D62-16-15-18-12-26-18-12-4493152
10/14/08 12:20
10/10/08
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d3316.18621004D8258144-7-14212-1-7-2116
10/14/08 12:20
10/10/08
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.d-2823.676-1-234D8258144-7-14212-1-7-2116
8/4/08 14:46
8/4/08
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d3812.9633999%3D10235866177003-58-37
8/4/08 14:46
8/4/08
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.d-7926.803-3-483D10235866177003-58-37
4/8/08 09:31
4/7/08
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d6113.63353D796985-112132-2-9-6-17-2-20
4/8/08 09:31
4/7/08
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.d-12527.683-5-593D796985-112132-2-9-6-17-2-20
10/25/07 12:35
10/24/07
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.dm4510.91343D10184473318-100265-6-115
10/25/07 12:35
10/24/07
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.dm-10425.333-4-573D10184473318-100265-6-115
9/12/07 16:04
9/11/07
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.ad156.53422713D10266482313104-3-2-315151920
9/12/07 15:34
5/11/07
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d156.53422713D10266482313104-3-1-414131818
8/9/07 19:25
8/9/07
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d2715.20321D875733206382-139272432
8/9/07 19:25
8/9/07
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.d-5330.493-2-761D875733206382-139272432
5/11/07 17:22
5/11/07
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d5315.20241D1021426119421256195950
5/11/07 17:22
5/11/07
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.d-8925.532-4-861D1021426119421256195950
11/9/06 16:43
11/7/06
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d159.80221D57-119-50-2-1111102999
11/9/06 16:43
11/7/06
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.d-3120.352-2-731D57-119-50-2-1111102999
8/23/06 08:24
8/21/06
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d2318.72111D-116-16-22-51130672557
8/23/06 08:24
8/21/06
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.d-2318.721-1-691D-116-16-22-51130672557
11/8/05 14:55
11/8/05
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPM.d5610.15160D165501917221-12613196
11/8/05 14:55
11/8/05
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVPS.d-10318.801-6-940D165501917221-12613196
1/12/04 12:06
1/8/04
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticMozola Mark AOVP of R,S.dm-8120.163-4-960D5173373622660-102-14-8-3

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact